I saw a figure of 80% hospitalized were not vaccinated OR had comorbidities. That's still a significant amount of breakthroughs, especially if they're using a liberal definition of comorbidities.https://www.aljazeera.com/news/2021/5/12/who-reviewing-seychelles-data-after-fully-vaccinated-get-covid …
-
-
Replying to @Noahpinion @zeynep
In other words, 20% of the people getting hospitalized are vaccinated AND have no comorbidities. Given that most of the patients hospitalized before vaccination had comorbidities, this is not super reassuring to me.https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777028 …
4 replies 4 retweets 29 likes -
Replying to @Noahpinion @zeynep
Noah Smith 🐇 Retweeted Noah Smith 🐇
Yes, it's a small country, so the comparison is difficult. Bahrain is also very small, but 16 times larger than Seychelles, and we're seeing a similar phenomenon there. So, I am concerned.https://twitter.com/Noahpinion/status/1394443930419142656 …
Noah Smith 🐇 added,
8 replies 5 retweets 31 likes -
Replying to @Noahpinion
You’re again comparing a tiny country with extensive testing capacity and vaccination, with a one billion+ person country with 45% test positivity in some states and a mostly unvaccinated population. Even what a “confirmed case” means in Bahrain is not the same thing as India.
4 replies 3 retweets 44 likes -
Replying to @zeynep
OK. But compare it to any other country, and it's still cause for concern.
3 replies 0 retweets 8 likes -
-
Replying to @zeynep
The concern is that the Sinopharm vaccine is considerably less effective than other vaccines. Remember, this is a vaccine that we never got really good data on to begin with.https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-who-experts-voice-very-low-confidence-some-sinopharm-covid-19-vaccine-2021-05-05/ …
3 replies 3 retweets 32 likes -
Replying to @Noahpinion @zeynep
If it turns out that Sinopharm is substantially less effective than other vaccines, that should affect countries' decision of which vaccine to purchase, and it should make exporting mRNA vaccines a more urgent priority for the U.S.
5 replies 3 retweets 68 likes -
Replying to @Noahpinion @zeynep
mRNA, but also J&J, Novavax, and AstraZeneca - all seem to provide substantially more protection against the new variants than Sinopharm. I'm curious about Sputnik and the Indian Covaxin.
4 replies 0 retweets 9 likes -
Inactivated virus vaccine like Covaxin inherently more protective against all emerging variants with it's whole virion approach targeting all virus proteins. One and done. Or at least two shots, a booster months later and possibly done.
1 reply 0 retweets 0 likes
zeynep tufekci Retweeted Michael Lin, MD PhD 🧬
Actually, no, almost certainly needs the booster and probably more away from "one and done" compared to many other types of vaccines.https://twitter.com/michaelzlin/status/1396222641241919490 …
zeynep tufekci added,
-
-
Compared to other vaccines? The others are all about boosters for each emerging variant.
0 replies 0 retweets 0 likesThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.